Terms: = Brain cancer AND HOXD13, SPD, 3239, P35453, HOX4I
24 results:
1. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.
Malta TM; Sabedot TS; Morosini NS; Datta I; Garofano L; Vallentgoed W; Varn FS; Aldape K; D'Angelo F; Bakas S; Barnholtz-Sloan JS; Gan HK; Hasanain M; Hau AC; Johnson KC; Cazacu S; deCarvalho AC; Khasraw M; Kocakavuk E; Kouwenhoven MCM; Migliozzi S; Niclou SP; Niers JM; Ormond DR; Paek SH; Reifenberger G; Sillevis Smitt PA; Smits M; Stead LF; van den Bent MJ; Van Meir EG; Walenkamp A; Weiss T; Weller M; Westerman BA; Ylstra B; Wesseling P; Lasorella A; French PJ; Poisson LM; ; Verhaak RGW; Iavarone A; Noushmehr H
Cancer Res; 2024 Mar; 84(5):741-756. PubMed ID: 38117484
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
Schuler A; Huser J; Schmid S; Schär S; Scherz A; Gautschi O; Mauti L; von Briel T; Waibel C; Wannesson L; Pankovics J; Mark MT; Rothschild SI; Addeo A; Janthur WD; Siano M; Boos L; Britschgi C; Früh M
Lung Cancer; 2024 Jan; 187():107427. PubMed ID: 38043395
[TBL] [Abstract] [Full Text] [Related]
3. Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
Cheng CL; Yao CY; Huang PH; Yu CW; Fang WQ; Chuang WH; Wu SJ; Lin YJ; Hung YC; Tsai CH; Yu SC; Chou WC; Tien HF
Br J Haematol; 2023 Apr; 201(1):75-85. PubMed ID: 36480431
[TBL] [Abstract] [Full Text] [Related]
4. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
5. The Change of Soluble Programmed Death Ligand 1 (spd-L1) in Plasma of Small Cell Lung cancer and Its Clinical Significance.
Lu F; Dong Y; Li Q; Wang M
Comput Math Methods Med; 2022; 2022():8375349. PubMed ID: 35126639
[TBL] [Abstract] [Full Text] [Related]
6. The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor.
Nie D; Fang Q; Cheng J; Li B; Li M; Wang H; Li C; Gui S; Zhang Y; Zhao P
Cancer Immunol Immunother; 2022 May; 71(5):1233-1245. PubMed ID: 34647152
[TBL] [Abstract] [Full Text] [Related]
7. Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma.
Mair MJ; Ilhan-Mutlu A; Pajenda S; Kiesel B; Wöhrer A; Widhalm G; Dieckmann K; Marosi C; Wagner L; Preusser M; Berghoff AS
Cancer Immunol Immunother; 2021 Dec; 70(12):3643-3650. PubMed ID: 33956203
[TBL] [Abstract] [Full Text] [Related]
8. The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
Ding XC; Wang LL; Zhu YF; Li YD; Nie SL; Yang J; Liang H; Weichselbaum RR; Yu JM; Hu M
Front Immunol; 2020; 11():580335. PubMed ID: 33224142
[TBL] [Abstract] [Full Text] [Related]
9. Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours.
Mair MJ; Pajenda S; Ilhan-Mutlu A; Steindl A; Kiesel B; Widhalm G; Dieckmann K; Feldmann K; Hainfellner J; Marosi C; Müllauer L; Wagner L; Preusser M; Berghoff AS
ESMO Open; 2020 Nov; 5(6):e000863. PubMed ID: 33184096
[TBL] [Abstract] [Full Text] [Related]
10. A novel miR-7156-3p-hoxd13 axis modulates glioma progression by regulating tumor cell stemness.
Zhang J; Deng M; Tong H; Xue W; Guo Y; Wang J; Chen L; Wang S
Int J Biol Sci; 2020; 16(16):3200-3209. PubMed ID: 33162825
[TBL] [Abstract] [Full Text] [Related]
11. Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Weidner H; Baschant U; Lademann F; Ledesma Colunga MG; Balaian E; Hofbauer C; Misof BM; Roschger P; Blouin S; Richards WG; Platzbecker U; Hofbauer LC; Rauner M
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759495
[TBL] [Abstract] [Full Text] [Related]
12. CD24 and PRAME Are Novel Grading and Prognostic Indicators for Pineal Parenchymal Tumors of Intermediate Differentiation.
Wu X; Wang W; Lai X; Zhou Y; Zhou X; Li J; Liang Y; Zhu X; Ren X; Ding Y; Liang L
Am J Surg Pathol; 2020 Jan; 44(1):11-20. PubMed ID: 31567202
[TBL] [Abstract] [Full Text] [Related]
13. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of perioperative automated versus manual two-dimensional tumor analysis in glioblastoma patients.
Kellner-Weldon F; Stippich C; Wiest R; Lehmann V; Meier R; Beck J; Schucht P; Raabe A; Reyes M; Bink A
Eur J Radiol; 2017 Oct; 95():75-81. PubMed ID: 28987701
[TBL] [Abstract] [Full Text] [Related]
15. Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
Eidel O; Burth S; Neumann JO; Kieslich PJ; Sahm F; Jungk C; Kickingereder P; Bickelhaupt S; Mundiyanapurath S; Bäumer P; Wick W; Schlemmer HP; Kiening K; Unterberg A; Bendszus M; Radbruch A
PLoS One; 2017; 12(1):e0169292. PubMed ID: 28103256
[TBL] [Abstract] [Full Text] [Related]
16. Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.
Porz N; Habegger S; Meier R; Verma R; Jilch A; Fichtner J; Knecht U; Radina C; Schucht P; Beck J; Raabe A; Slotboom J; Reyes M; Wiest R
PLoS One; 2016; 11(11):e0165302. PubMed ID: 27806121
[TBL] [Abstract] [Full Text] [Related]
17. Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association.
Hilger AC; Halbritter J; Pennimpede T; van der Ven A; Sarma G; Braun DA; Porath JD; Kohl S; Hwang DY; Dworschak GC; Hermann BG; Pavlova A; El-Maarri O; Nöthen MM; Ludwig M; Reutter H; Hildebrandt F
Hum Mutat; 2015 Dec; 36(12):1150-4. PubMed ID: 26294094
[TBL] [Abstract] [Full Text] [Related]
18. DNA methylation profiles of long- and short-term glioblastoma survivors.
Shinawi T; Hill VK; Krex D; Schackert G; Gentle D; Morris MR; Wei W; Cruickshank G; Maher ER; Latif F
Epigenetics; 2013 Feb; 8(2):149-56. PubMed ID: 23291739
[TBL] [Abstract] [Full Text] [Related]
19. An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy.
Attanasio R; Montini M; Valota M; Cortesi L; Barbò R; Biroli F; Tonnarelli G; Albizzi M; Testa RM; Pagani G
Pituitary; 2008; 11(1):1-11. PubMed ID: 17690987
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and familial risks in pituitary adenoma and associated tumors.
Hemminki K; Försti A; Ji J
Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
[TBL] [Abstract] [Full Text] [Related]
[Next]
